Betraying the Parasite’s Redox System: Diaryl Sulfide‐Based Inhibitors of Trypanothione Reductase: Subversive Substrates and Antitrypanosomal Properties

Trypanosoma and Leishmania are the causative agents of African sleeping sickness (Trypanosoma brucei), Chagas disease (Trypanosoma cruzi), and the different forms of leishmaniasis (for example, Leishmania donovani). All these tropical diseases cause many thousands of deaths annually, and African sleeping sickness and leishmaniasis are categorized as an emerging or uncontrolled (category 1) disease by the world health organization (WHO). The drugs currently in use show severe side effects, are often difficult to administrate, and are inefficient in the late stages of infection. In addition, the parasites show increasing drug resistance. This generates the urgent need for new antiparasitic agents. A promising approach in the fight against these diseases is to interfere with the redox metabolism of the parasites. In trypanosomatids, the nearly ubiquitous glutathione system is replaced by a trypanothione system. The key enzyme of the unique thiol metabolism is trypanothione reductase (TR, EC 1.8.1.12) which catalyzes the reduction of trypanothione disulfide (TS2, 1) to trypanothione (T(SH)2, 2) (Scheme 1). The NADPH dependent flavoprotein is the complement of human glutathione reductase (hGR, EC 1.8.1.7) and is essential for the parasites, rendering the enzyme an attractive drug target. An artful option to increase the efficiency of compounds interfering with redox enzymes such as TR is to incorporate structural motives into inhibitors, enabling them to convert the antioxidative disulfide reductase into a pro-oxidative enzyme. Redox-active compounds capable of such transformations have been termed turncoat inhibitors or subversive substrates. Distinguished by a functional group with a low one-electron reduction potential, such a subversive substrate X can be reduced by the flavoprotein to a radical anion X C, which can be reoxidized by molecular oxygen liberating superoxide anion radicals [Equations (1) and (2)] . This enzyme-catalyzed redox cycling process leads to the prodigality of NADPH and molecular oxygen, and the simultaneous release of toxic reactive oxygen species inside the parasites. Such compounds therefore act as catalysts for oxidative stress. The known sensitivity of parasitic protozoa towards reagents promoting free radical damage in cells renders this strategy a promising route to new, potent agents against the pathogens.

[1]  Elias S. J. Arnér,et al.  Interactions of Nitroaromatic Compounds with the Mammalian Selenoprotein Thioredoxin Reductase and the Relation to Induction of Apoptosis in Human Cancer Cells* , 2006, Journal of Biological Chemistry.

[2]  A. Fairlamb,et al.  Drug Resistance in Leishmaniasis , 2006, Clinical Microbiology Reviews.

[3]  V. Yardley,et al.  Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide. , 2005, Journal of medicinal chemistry.

[4]  A. Fairlamb Chemotherapy of human African trypanosomiasis: current and future prospects. , 2003, Trends in parasitology.

[5]  Eva Liebau,et al.  Thiol-based redox metabolism of protozoan parasites. , 2003, Trends in parasitology.

[6]  Fabio Zicker,et al.  Strategic emphases for tropical diseases research: a TDR perspective. , 2002, Trends in parasitology.

[7]  S. Daunes,et al.  The therapeutic potential of inhibitors of the trypanothione cycle , 2002, Expert opinion on investigational drugs.

[8]  M. Barrett,et al.  Chemotherapy of human African trypanosomiasis. , 2002, Current pharmaceutical design.

[9]  N. Čėnas,et al.  Antiplasmodial activity of nitroaromatic and quinoidal compounds: redox potential vs. inhibition of erythrocyte glutathione reductase. , 2001, Archives of biochemistry and biophysics.

[10]  V. Yardley,et al.  2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. , 2001, Journal of medicinal chemistry.

[11]  J. Keiser,et al.  New drugs for the treatment of human African trypanosomiasis: research and development. , 2001, Trends in parasitology.

[12]  V. Yardley,et al.  Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase. , 1999, Biochemical pharmacology.

[13]  M. Barrett The fall and rise of sleeping sickness , 1999, The Lancet.

[14]  P. Karplus,et al.  Kinetics and Crystallographic Analysis of Human Glutathione Reductase in Complex with a Xanthene Inhibitor (*) , 1996, The Journal of Biological Chemistry.

[15]  C. Sergheraert,et al.  2-Amino diphenylsulfides as new inhibitors of trypanothione reductase. , 1995, International journal of antimicrobial agents.

[16]  Paul R. Gerber,et al.  MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..

[17]  J. Blanchard,et al.  Chinifur, a selective inhibitor and "subversive substrate" for Trypanosoma congolense trypanothione reductase. , 1994, Biochemical and biophysical research communications.

[18]  A. Fairlamb,et al.  Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. , 1992, The Biochemical journal.

[19]  A. Fairlamb,et al.  Metabolism and functions of trypanothione in the Kinetoplastida. , 1992, Annual review of microbiology.

[20]  A. Fairlamb,et al.  Synthesis of N-benzyloxycarbonyl-L-cysteinylglycine 3-dimethylaminopropylamide disulfide: a cheap and convenient new assay for trypanothione reductase. , 1991, Analytical biochemistry.

[21]  Jockers-Scherübl Mc,et al.  Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. , 1989 .

[22]  A. Fairlamb,et al.  "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Docampo,et al.  Generation of superoxide anion and hydrogen peroxide induced by nifurtimox in Trypanosoma cruzi. , 1979, Archives of biochemistry and biophysics.

[24]  S. Meshnick,et al.  An approach to the development of new drugs for African trypanosomiasis , 1978, The Journal of experimental medicine.

[25]  I. Fridovich,et al.  Superoxide dismutase: a comparison of rate constants. , 1973, Archives of biochemistry and biophysics.